Senior AI/ML Scientist – Drug Discovery & R&D Operations
ElancoSenior AI/ML Scientist – Drug Discovery & R&D Operations
ElancoLocation
Indianapolis, IN
Type
Full-time
Posted
9/11/2026
Compensation
Not listed
Job description
The Senior AI/ML Scientist at Elanco will focus on accelerating R&D by developing predictive models from scientific data to guide drug discovery and development decisions. This role involves collaboration with discovery and development scientists to create machine learning and computer-vision models. The position emphasizes the importance of diversity and innovation within the team. The successful candidate will lead projects that enhance animal health through advanced data analysis and modeling techniques.
Requirements
- PhD in a quantitative field or a Master's degree with substantial hands-on ML/CV experience.
- 7+ years of industry experience building and deploying ML and computer-vision models for scientific problems.
- Strong Python skills and proficiency with modern ML/CV libraries.
- Solid understanding of statistics and experimental design.
- Proven ability to work and communicate effectively in cross-functional environments.
Responsibilities
- Lead ML/CV work for key R&D programs by partnering with scientists.
- Design, build, and validate advanced ML and computer-vision models on multi-modal data.
- Shape data collection and annotation processes by collaborating with experimental teams.
- Operationalize models in R&D workflows and integrate them with tools used by scientists.
- Provide technical leadership and mentorship to junior scientists.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
